BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
26 hedge funds and large institutions have $4.12M invested in Baudax Bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
26
Holding in Top 10
–
Calls
$180K
Puts
–
Top Buyers
| 1 | +$167K | |
| 2 | +$91.3K | |
| 3 | +$65.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$40K |
| 5 |
BlackRock
New York
|
+$12.2K |
Top Sellers
| 1 | -$225K | |
| 2 | -$115K | |
| 3 | -$21.7K | |
| 4 |
PCM
Pinz Capital Management
New York
|
-$16K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$11.3K |